12/28/22 8:00 AMAMEX : CPHI China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective MaskChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the launch of N95 medicalRHEA-AIneutral
12/15/22 8:00 AMAMEX : CPHI covid-19China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its drugs were listed in TheRHEA-AIneutral
12/05/22 8:00 AMAMEX : CPHI acquisitionChina Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device ProjectChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the Acquisition of Dry Eye DiseaseRHEA-AIneutral
12/02/22 4:10 PMAMEX : CPHI China Pharma Announces Receipt of Noncompliance Notice from NYSE AmericanChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on December 1, 2022, received a notification (the "Deficiency Letter") from the NYSE American LLC (theRHEA-AInegative
10/01/22 10:05 PMAMEX : CPHI China Pharma Announces Receipt of Notification of NYSE American Listing DeficiencyChina Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022, the Company received notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") informing it that the Company is not inRHEA-AIneutral
07/18/22 8:00 AMAMEX : CPHI China Pharma Announced the Submission of a Plan of Compliance to NYSE AmericanChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC ("NYSE American" or theRHEA-AIneutral
06/22/22 5:00 PMAMEX : CPHI China Pharma Announces Receipt of Noncompliance Notice from NYSE AmericanChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on June 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or theRHEA-AIneutral
03/31/22 8:00 AMAMEX : CPHI earningsChina Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial ResultsChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscalRHEA-AIneutral
11/12/21 4:30 PMAMEX : CPHI earningsChina Pharma Holdings, Inc. Reports Third Quarter 2021 Financial ResultsChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for theRHEA-AIneutral
08/13/21 4:30 PMAMEX : CPHI earningsChina Pharma Holdings, Inc. Reports Second Quarter 2021 Financial ResultsChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for theRHEA-AIneutral